[1]
Mostofa, A.G. et al. 2021. Comparison of anti-thrombotic strategies using Bivalirudin, Heparin plus Eptifibatide, and Unfractionated Heparin Monotherapy for acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI): A single-center observational stu. University Heart Journal. 17, 2 (Jun. 2021), 91–98. DOI:https://doi.org/10.3329/uhj.v17i2.54364.